Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma

MLA

Jiao Wang, et al. “Statin Therapy: A Potential Adjuvant to Immunotherapies in Hepatocellular Carcinoma.” Frontiers in Pharmacology, vol. 15, Feb. 2024. EBSCOhost, https://doi.org/10.3389/fphar.2024.1324140.

APA

Jiao Wang, Chengyu Liu, Ronghua Hu, Licheng Wu, & Chuanzhou Li. (2024). Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1324140

Chicago

Jiao Wang, Chengyu Liu, Ronghua Hu, Licheng Wu, and Chuanzhou Li. 2024. “Statin Therapy: A Potential Adjuvant to Immunotherapies in Hepatocellular Carcinoma.” Frontiers in Pharmacology 15 (February). doi:10.3389/fphar.2024.1324140.